Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Part of paid clinical trials in Scottsdale, Arizona.
- Sponsor
- 4D Molecular Therapeutics
- Study ID
- NCT07064759
- Phase
- PHASE3
- Status
- Recruiting
Conditions
- Neovascular Age-Related Macular Degeneration (nAMD)
Eligibility Criteria
- Sex
- ALL
- Age
- 50 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- 4D-150 IVT (3E10 vg/eye) — BIOLOGICALIf randomized to the 4D-150 treatment arm, 4D-150 will be administered at the assigned dose level as a single dose IVT injection on Day 1
- EYLEA® (aflibercept) Injection 2 mg (0.05mL) — BIOLOGICALEylea (aflibercept) will be administered at applicable visits
Study Details
A Phase 3, Randomized, Double-Masked, Active-Controlled Trial in Adults with Macular Neovascularization Secondary to Age-Related Macular Degeneration
Key Dates
- Start date
- Jul 22, 2025
- Status verified
- Apr 2026
- Primary completion
- Nov 30, 2028
- Completion
- Feb 28, 2029
Study Design
- Enrollment
- 480 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: 4D-150 IVT (3E10 vg/eye)
- Active Comparator: Aflibercept (AFLB) 2 mg IVT
Primary Outcome Measure
Mean change from baseline in Best Corrected Visual Accuity (BCVA) Early Treatment for Diabetic Retinopathy (ETDRS) letter score at Week 52 [ Time Frame: 52 Weeks ]
Central Contacts
- 4DMT Patient Advocacy(888) 748-8881
Locations (54)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Research Network Arizona | Scottsdale | Arizona | 85255 | Mark Barakat, MD (PRINCIPAL_INVESTIGATOR) |
| Barnet Dulaney Perkins Eye Center | Sun City | Arizona | 85351 | Suhail Alam, MD (PRINCIPAL_INVESTIGATOR) |
| Retina Associates | Tucson | Arizona | 85704 | Cameron Javid, MD (PRINCIPAL_INVESTIGATOR) |
| Retinal Diagnostic Center | Campbell | California | 95008 | Amr Dessouki, MD (PRINCIPAL_INVESTIGATOR) |
| Retina Consultants of Orange County | Fullerton | California | 92835 | Ashkan Pirouz, MD (PRINCIPAL_INVESTIGATOR) |
| Northern California Retina Vitreous Associates | Mountain View | California | 94040 | Mark Wieland, MD (PRINCIPAL_INVESTIGATOR) |
| Retinal Consultants Medical Group | Sacramento | California | 95841 | Margaret Chang, MD (PRINCIPAL_INVESTIGATOR) |
| Retinal Consultants Medical Group Inc. | Sacramento | California | 95825 | Joel Pearlman, MD, PhD (PRINCIPAL_INVESTIGATOR) |
| West Coast Retina Medical Group | San Francisco | California | 94109 | Michael Jumper, MD (PRINCIPAL_INVESTIGATOR) |
| Bay Area Retina Associates | Walnut Creek | California | 94598 | Subhransu Ray, MD, PhD (PRINCIPAL_INVESTIGATOR) |
| Retina Consultants of Southern Colorado P.C. | Colorado Springs | Colorado | 80909 | Standford Taylor, MD (PRINCIPAL_INVESTIGATOR) |
| Southwest Retina Consultants | Durango | Colorado | 81303 | Sara Haug, MD, PHD (PRINCIPAL_INVESTIGATOR) |
| ClearVista Clinical Research | Hudson | Florida | 34667 | Dana Deupree, MD, FASRS (PRINCIPAL_INVESTIGATOR) |
| Florida Retina Institute | Orlando | Florida | 32806 | Matthew Cunningham, MD, PhD (PRINCIPAL_INVESTIGATOR) |
| Retina Specialty Institute | Pensacola | Florida | 32503 | Sunil Gupta, MD (PRINCIPAL_INVESTIGATOR) |
| Retina Vitreous Associates of Florida | St. Petersburg | Florida | 33711 | David Eichenbaum, MD, FASRS (PRINCIPAL_INVESTIGATOR) |
| East Florida Eye Institute | Stuart | Florida | 34994 | Ronald Frenkel, MD (PRINCIPAL_INVESTIGATOR) |
| Retina Vitreous Associates of Florida | Tampa | Florida | 33617 | Ashley Crane, MD (PRINCIPAL_INVESTIGATOR) |
| Thomas Eye Group | Sandy Springs | Georgia | 30328 | Paul Kaufman, MD (PRINCIPAL_INVESTIGATOR) |
| Retina Associates, Ltd. | Elmhurst | Illinois | 60126 | Aaron Weinberg, MD (PRINCIPAL_INVESTIGATOR) |
| University Retina and Macula Associates, PC | Oak Forest | Illinois | 60452 | Veeral Sheth, MD, MBA, FACS, FASRS (PRINCIPAL_INVESTIGATOR) |
| Illinois Retina Associates | Oak Park | Illinois | 60304 | Mathew MacCumber, MD, PhD (PRINCIPAL_INVESTIGATOR) |
| Springfield Clinic | Springfield | Illinois | 62703 | Ramanath Bhandari, MD (PRINCIPAL_INVESTIGATOR) |
| Retina Partners Midwest, PC | Carmel | Indiana | 46032 | Raj Maturi, MD, FASRS (PRINCIPAL_INVESTIGATOR) |
| The Retina Care Center | Baltimore | Maryland | 21209 | Matthew Speicher, MD (PRINCIPAL_INVESTIGATOR) |
| Cumberland Valley Retina Consultants | Hagerstown | Maryland | 21740 | Allen Hu, MD (PRINCIPAL_INVESTIGATOR) |
| Mid Atlantic Retina Specialist | Hagerstown | Maryland | 21740 | Adam Gerstenblith, MD (PRINCIPAL_INVESTIGATOR) |
| New England Retina Consultants | Springfield | Massachusetts | 01107 | David Lally, MD (PRINCIPAL_INVESTIGATOR) |
| Foundation for Vision Research | Grand Rapids | Michigan | 49546 | Thomas Aaberg, MD (PRINCIPAL_INVESTIGATOR) |
| Sierra Eye Associates | Reno | Nevada | 89502 | Arshad Khanani, MD, MA, FASRS (PRINCIPAL_INVESTIGATOR) |
| Envision Ocular, LLC | Bloomfield | New Jersey | 07003 | Patrick Higgins, MD (PRINCIPAL_INVESTIGATOR) |
| Retina Vitreous Surgeons of CNY PC | Liverpool | New York | 13088 | Jamin Brown, MD (PRINCIPAL_INVESTIGATOR) |
| New York Presbyterian Hospital - Columbia University Medical Center | New York | New York | 10032 | Tongalp Tezel, MD (PRINCIPAL_INVESTIGATOR) |
| Vitreoretinal Consultants of NY | Westbury | New York | 11590 | James Lin, MD (PRINCIPAL_INVESTIGATOR) |
| North Carolina Retina Associates | Cary | North Carolina | 27511 | Rebecca Manning, MD (PRINCIPAL_INVESTIGATOR) |
| North Carolina Retina Associates | Wake Forest | North Carolina | 27587 | John Thordsen, MD (PRINCIPAL_INVESTIGATOR) |
| Cincinnati Eye Institute | Cincinnati | Ohio | 45242 | Robert Sisk, MD, FACS, FASRS (PRINCIPAL_INVESTIGATOR) |
| Verum Research, LLC | Eugene | Oregon | 947401 | Albert Edwards, MD, PhD, MBA (PRINCIPAL_INVESTIGATOR) |
| EyeHealth Northwest | Portland | Oregon | 97233 | Brian Chan-Kai, MD (PRINCIPAL_INVESTIGATOR) |
| Erie Retina Research | Erie | Pennsylvania | 16505 | David Almeida, MD, MBA, PhD, DABO, FRCSC, FAS (PRINCIPAL_INVESTIGATOR) |
| Charleston Neuroscience Institute, LLC | Bluffton | South Carolina | 29910 | Mona Camacci, MD, MS (PRINCIPAL_INVESTIGATOR) |
| Carolina Eyecare | Mt. Pleasant | South Carolina | 29464 | Jonathan Brugger, MD (PRINCIPAL_INVESTIGATOR) |
| Palmetto Retina Center | West Columbia | South Carolina | 29169 | Stephen Hypes, DO (PRINCIPAL_INVESTIGATOR) |
| Black Hills Regional Eye Institute | Rapid City | South Dakota | 57701 | Prema Abraham, MD (PRINCIPAL_INVESTIGATOR) |
| Tennessee Retina, PC | Nashville | Tennessee | 37203 | Carl Awh, MD, FASRS (PRINCIPAL_INVESTIGATOR) |
| Southwest Retina Specialist - Panhandle Eye group, LLP | Amarillo | Texas | 79106 | Jason Edward Ysasaga, MD (PRINCIPAL_INVESTIGATOR) |
| Austin Clinical Research | Austin | Texas | 78750 | Fuad Makkouk, MD (PRINCIPAL_INVESTIGATOR) |
| Texas Retina Associate | Dallas | Texas | 75231 | Ashkan Abbey, MD, FASRS, FAAO (PRINCIPAL_INVESTIGATOR) |
| Tyler Retina Consultants | Tyler | Texas | 75703 | Samuel Minaker, MD (PRINCIPAL_INVESTIGATOR) |
| Strategic Clinical Research | Willow Park | Texas | 76087 | Seong Young Lee, MD (PRINCIPAL_INVESTIGATOR) |
| Rocky Mountain Retina Consultants | Salt Lake City | Utah | 84107 | Mitchell Goff, MD (PRINCIPAL_INVESTIGATOR) |
| Piedmont Eye Center | Lynchburg | Virginia | 24502 | Golnaz Javey, MD (PRINCIPAL_INVESTIGATOR) |
| Pacific Northwest Retina | Silverdale | Washington | 98383 | Todd Schneiderman, MD, FASRS (PRINCIPAL_INVESTIGATOR) |
| Eye Clinic of Wisconsin | Wausau | Wisconsin | 54403 | Deepak Sambhara, MD, FASRS (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Scottsdale, AZ
Related Studies
- Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMDEnrolling By Invitation · AbbVie · Phoenix, Arizona
- A Phase 3 Clinical Trial to Compare RBS-001 to Eylea® in Subjects With Neovascular Age-Related Macular DegenerationPHASE3 · Not Yet Recruiting · Rophibio, Inc. · Phoenix, Arizona
- Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)PHASE3 · Recruiting · Adverum Biotechnologies, Inc. · Phoenix, Arizona
- Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 StudyPHASE3 · Not Yet Recruiting · Ocular Therapeutix, Inc. · Santa Barbara, California